Nucleocapside-directed IgM antibodies have been identified as the initial serological marker during infection, becoming detectable in a median of 2–3 days after disease onset, followed by glycoprotein precursor (GPC) directed IgM (4–6 days) and IgG antibodies (5–6 days) [28]. This evidence concerns the gene CD40LG and infection.